DFTX · Definium Therapeutics, Inc. · Investor Relations
$37.40
-0.20 (-0.53%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$5.10B
Shares
134.37M
Volume · Oct 2
1.6M
Avg daily vol (3M)
2.14M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-23 | TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit | Event |
| 2026-09-19 | Psych Congress 2026 | Event |
| 2026-08-12 | Phase 3 Voyage Topline Results: DT120 ODT in Generalized Anxiety Disorder | Event |
| 2026-08-06 | Q2 2026 Earnings Conference Call | Earnings call |
| 2026-08-06 | Q2 2026 Earnings Call | Earnings call |
| 2026-06-22 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-06-22 | Phase 3 Emerge Topline Results: DT120 ODT in Major Depressive Disorder | Event |
| 2026-05-07 | Q1 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-02-26 | Earnings conference call (announced in 8-K) | Earnings call |
Source: https://ir.definiumtx.com/